跳至主要内容
临床试验/NCT00628199
NCT00628199Enrolling By Invitation不适用

Derivation of Primary Donor Cell Lines for Human Cell Reprogramming

Stanford University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2007年9月最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
60
试验地点
1

研究概览

简要总结

This is a research study in which your cells will be used for somatic cell nuclear transfer (SCNT), and/or genetic reprogramming research which may result in the production of stem cell lines. This study does not provide treatment.

详细描述

It is thought that studies of genetic reprogramming and SCNT using human cells have the potential to give us new basic knowledge about human development. Current work will focus on developing this basic knowledge. In the future, human embryonic stem cell lines (hESC) derived from genetic reprogramming and SCNT may also have the potential to develop into cell types that are useful for cell-based therapies to treat human disease and disability.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
1 Year 至 75 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Donors with a degenerative disease phenotype or genetic disorders such as Type I Diabetes, heart disease, or infertility (azoospermia and premature ovarian failure)

排除标准

  • Unable to read or understand English.
  • Unable to provide skin biopsy sample due to skin condition in the underarm area.

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Marius Wernig

Professor of Pathology

Stanford University

研究点 (1)

Loading locations...

相似试验